Overexpression of ABCA4 is associated with a complete chemotherapy response in advanced stages of ovarian carcinoma [46], which suggests that there is a positive effect on its overexpression in AR‐357‐treated LNCaP and PC3 cells. Here, ABCA4 is linked to ovarian carcinoma.